baber/WOPTO huggingface dataset:
Patent BR-PI1003995-B1 (BR)
Title: Embalagem para folhas de papel
Inventor: Nelson Luís Bertazzo Teruel
IPC: B65B11/00
Filed: 2010-08-16
Abstract: embalagem para folhas de papel. a presente invenção diz respeito a uma embalagem para folhas de papel para uso em escritórios, casas, centros gráficos, e outros, que as folhas podem ter diferentes tamanhos e possivelmente empregadas para obtenção de cópias e outros, a referida embalagem sendo compreendida, substancialmente, por um invólucro, obtido de um material não laminado, convenientemente recortado, dobrado, e termo-selado, compreendido, substancialmente, por só uma camada de filme de polipropileno bi-orientado o qual recebe uma impressão flexográfica ou impressão em rotogravura de micro pontos.
Patent BR-PI1016186-B1 (BR)
Title: "dispositivo (1) para dosar e tratar por aerossol material em forma de aerossol e sistema para dosar e nebulizar a seco material nebulizável
Inventor: GERHARD POHLMANN
IPC: A61M15/00
Filed: 2010-04-22
Abstract: dispositivo (1) para dosar e tratar por aerossol material em forma de aerossol e sistema para dosar e nebulizar a seco material nebulizável a presente invenção refere-se a um dispositivo para dosar e tratar por aerossol material em forma de aerossol. o dispositivo compreende: um corpo com um canal para tratar por aerossol com uma porção de fixação distal conectável a uma fonte de gás carreador que fornece impulsos de pressão para o canal tratado por aerossol; uma porção de fixação proximal para produzir material em forma de aerossol e um reservatório para receber material em forma de aerossol. o reservatório compreende paredes e é conectado de uma maneira à prova de gás ao corpo e em conexão de fluido com o canal tratado por aerossol. pelo menos parte das paredes do dispositivo é membrana autoexcitada que pode ser colocada em oscilação pelos impulsos de pressão.
Patent EA-007271-B1 (EA)
Title: Benzothia(dia)zine derivatives, method for preparing thereof and pharmaceutical compositions containing them
Inventor: CORDI ALEX
IPC: A61P25/22
Filed: 2002-12-20
Abstract: The invention concerns compounds of formula (I),wherein:Rrepresents a hydroxy group or a RCO-O- group;Rrepresents a hydrogen, halogen atom, a hydroxy group or a R'CO-O group;R, R', identical or different, represent represent linear or branched (C-C)alkyl optionally substituted by aryl, linear or branched (C-C)alkenyl optionally substituted by aryl, linear or branched (C-C)perhaloalkyl, (C-C)cycloalkyl, adamantyl, aryl or heteroaryl,Rrepresents hydrogen, linear or branched (C-C)alkyl or (C-C)cycloalkyl,A represents a CRRgroup or a NRgroup;Rrepresents a hydrogen atom or an alkyl group;their isomers and their addition salts to a pharmaceutically acceptable acid or base.Medicaments.
Patent EA-011123-B1 (EA)
Title: Oestrogen derivatives as inhibitors of steroid sulphatase
Inventor: LEESE MATTHEW
IPC: C07J41/00
Filed: 2004-02-20
Abstract: The present invention provides a compound comprising a steroidal ring system and an optional group R; selected from any one of -OH, a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group or a sulphonamide group; wherein the D ring of the steroidal ring system is substituted by a group Rof the formula -L-R, wherein L is an optional linker group and Ris selected from groups which are or which comprise one of a nitrite group, an alcohol, an ester, an ether, an amine and an alkene, provided that when Ris or comprises an alcohol, L is present and wherein the A ring of the steroidal ring system is substituted at position 2 or 4 with a group R, wherein Ris a hydrocarbyl group.
Patent EA-009853-B1 (EA)
Title: Net and mat
Inventor: GELFAND MATTHEW
IPC: E01B5/18
Filed: 2005-03-31
Abstract: An energy absorbing system is disclosed, said system spanning a roadway and including a net spanning the roadway, the net having a connecting member coupled to a top member, a middle member and a bottom member, and a mat arranged on the roadway, having a plurality of recesses to accommodate the net, when the net is in a lowered position.
Patent EA-012612-B1 (EA)
Title: Method for controlling mycosis in leguminous plants
Inventor: SPEAKMAN JOHN-BRYAN
IPC: A01N37/50
Filed: 2005-12-16
Abstract: The invention relates to a method for controlling rusting in leguminous plants by the application of orysastrobin. The invention also relates to mixtures of orysastrobin with a fungicidal active ingredient II of the group of azols, acylalanines, amine derivatives, anilinopyrimidines, dicarboximides, dithio-carbamates, heterocyclic compounds, phenyl pyrrols, cinnamic acid amides, and the like, or other fungicides according to the description. The invention further relates to agents and seeds containing said mixtures.
Patent EA-012810-B1 (EA)
Title: Dimeric iap inhibitors
Inventor: CONDON STEPHEN M
IPC: A61P35/00
Filed: 2006-02-27
Abstract: Molecular mimics of Smac are capable of modulating apoptosis through their interaction with cellular IAPs (inhibitor of apoptosis proteins). The mimetics are based on a monomer or dimer of the N-terminal tetrapeptide of IAP-binding proteins, such as Smac/DIABLO, Hid, Grim and Reaper, which interact with a specific surface groove of IAP. Also disclosed are methods of using these peptidomimetics for therapeutic purposes. In various embodiments of the invention the Smac mimetics of the invention are combined with chemotherapeutic agents, including, but not limited to topoisomerase inhibitors, kinase inhibitors, NSAIDs, taxanes and platinum containing compounds use broader language.
Patent EA-016398-B1 (EA)
Title: Transition metal complexes supported on activating fluorinated support
Inventor: PRADES FLORAN
IPC: C08F10/00
Filed: 2006-07-26
Abstract: The present invention discloses an active supported catalyst system comprising: a) one or more non-metallocene catalyst component; b) an alkylating agent; c) an activating functionalised and fluorinated support. It also discloses a method for preparing said active support and its use in the polymerisation of polar and non polar monomers.
Patent EA-013638-B1 (EA)
Title: Process for the production of amides
Inventor: TOBLER HANS
IPC: A01N43/26
Filed: 2006-09-14
Abstract: The present invention relates to a process for the preparation of compounds of formula (I) wherein R
Patent EA-018067-B1 (EA)
Title: Thiadiazole derivatives for the treatment of neuro degenerative diseases
Inventor: GRIFFIOEN GERARD
IPC: A61K31/496
Filed: 2007-02-07
Abstract: This invention provides specifically substituted 1,2,4-thiadiazole derivatives for use in the treatment of an α-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease.
Patent EA-018085-B1 (EA)
Title: Metal oxide hydrogels and hydrosols, their preparation and use
Inventor: KESSLER VADIM G
IPC: A61K47/34
Filed: 2007-06-12
Abstract: A process for preparing a hydrosol of one or more metal oxides, e.g. titanium dioxide, comprising preparing a metal alkoxide solution in a water-miscible organic solvent, e.g. an alcohol; providing an aqueous solvent; mixing the metal alkoxide solution with the aqueous solvent in a volume or weight proportion to form a single-phase aqueous sol colloid (hydrosol) of hydrated metal oxide in absence of a non-ionic block polymer surfactant. Also disclosed is a corresponding hydrogel; water-insoluble particles encapsulated in hydrated metal oxide and a process for their encapsulation; uses of the encapsulation products.
Patent EA-024109-B1 (EA)
Title: Protein kinases inhibitors
Inventor: BAUER SHAWN M
IPC: C07D417/12
Filed: 2009-04-16
Abstract: The present invention is directed to compounds of formula (I) and pharmaceutically acceptable tautomers, salts, or stereoisomers thereof which are inhibitors of syk and/or JAK kinase. The present invention is also directed to intermediates used in making such compounds, the preparation of such compounds, pharmaceutical compositions containing such compounds, methods of inhibition of syk and/or JAK kinase activity, methods of inhibition of the platelet aggregation, and methods to prevent or treat a number of conditions mediated at least in part by syk and/or JAK kinase activity, such as adverse thrombosis and non-Hodgkin's lymphoma.
Patent EA-020251-B1 (EA)
Title: Biocompatible biodegradable fumagillin analog conjugates
Inventor: AKULLIAN LAURA C
IPC: A61K47/48
Filed: 2008-11-24
Abstract: Fumagillin analog polymer conjugates, methods of making fumagillin analog polymer conjugates, compositions comprising a polymer conjugate of a fumagillin analog, and methods for treating cancer, or treating angiogenic diseases comprising administering to a subject in need thereof an effective amount of a polymer conjugate of a fumagillin analog, are described. Also described are novel fumagillin analogs, methods of making fumagillin analogs, compositions comprising at least one fumagillin analog, and methods for treating cancer, or treating angiogenic diseases comprising administering to a subject in need thereof an effective amount of a fumagillin analog.
Patent EA-019640-B1 (EA)
Title: Indole derivatives and use thereof as glucokinase activators
Inventor: YASUMA TSUNEO
IPC: A61K31/427
Filed: 2009-04-09
Abstract: The present invention aims to provide a glucokinase activator useful as a pharmaceutical agent such as an agent for the prophylaxis or treatment of diabetes, obesity and the like. The present invention provides a glucokinase activator containing a compound represented by the formula (I)wherein each symbol is defined in the specification, or a salt thereof or a prodrug thereof.
Patent EA-018399-B1 (EA)
Title: Device for smoothing the surface of a sinter mixture
Inventor: BAROWSKI HELMUT
IPC: C21B13/00
Filed: 2009-09-15
Abstract: This invention relates to a device for smoothing the surface of a sinter mixture in a grate carriage (1), before the same enters an ignition furnace (2), by means of at least one scraper (3) between the charging point (4) of the sinter bed mixture and the ignition furnace (2), wherein the at least one scraper (3) is suspended above the travelling way (5) of the grate carriage (1) so as to reciprocate in and against its direction of travel such that the scraper (3) drags along the sinter bed surface when the grate carriage (1) moves through below the same.
Patent EA-022554-B1 (EA)
Title: Facade insulation
Inventor: WINTELER HANS
IPC: E04F13/08
Filed: 2011-01-18
Abstract: The invention relates to a facade insulation (11) with at least one carrier rail (23) which is arranged on an outer wall (19) of a building and with a plurality of thermal insulation panels (13) which are carried by the carrier rail (23). The carrier rail (23) is spaced apart from the outer wall (19) by at least two spacers (29). To transfer the weight of the thermal insulation panels (13) to the outer wall (19), at least two tension brackets (35) are provided which can each be fixed by a first end to the carrier rail (23) and by a second end to the outer wall (19). The invention also relates to an assembly kit for retaining thermal insulation panels (13) on an outer wall (19) of a building. The assembly kit comprises at least one carrier rail (23), at least two spacers (29), at least two tension brackets (35) and at least one wall fastening element (33).
Patent EA-023022-B1 (EA)
Title: High concentration parenteral composition of paracetamol and process for preparing the same
Inventor: PATEL KETAN R
IPC: A61K47/22
Filed: 2011-06-29
Abstract: The invention relates to a high concentration parenteral composition of paracetamol or a pharmaceutically acceptable salt thereof, provided for delivering a therapeutic dose of 500 mg paracetamol in 2-3 ml in a water solvent system, wherein the concentration of paracetamol or a pharmaceutically acceptable salt thereof is 166-250 mg/ml and viscosity is 7-28 cps at 25°C, the solvent system comprising glycofurol, ethanol and water or glycofurol, ethanol, polyethylene glycol and water. The invention also relates to a process for preparing said composition, comprising: a. solubilising the requisite quantities of paracetamol or a pharmaceutically acceptable salt thereof in a solvent system, such as glycofurol, ethanol and water or glycofurol, ethanol, polyethylene glycol and water, under inert atmosphere; b. adding antioxidant, chelating agent, benzyl alcohol; c. adjusting pH between 4 to 8; d. adjusting the volume of the solution to a preset volume; e. filtering the solution through 0.22 micron filter media; wherein the steps b and c are optional. The compositions remain stable clear and transparent for at least 6 hours after dilution.
Patent EA-024293-B1 (EA)
Title: COMPOUNDS AND COMPOSITIONS AS c-kit KINASE INHIBITORS
Inventor: YEH VINCE
IPC: C07D471/04
Filed: 2012-08-28
Abstract: The invention provides compounds of formulae (Ia) and (IIa), wherein the radical meanings are defined in the claims, and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of c-kit or c-kit and PDGFR (PDGFRα, PDGFRβ) kinases.
Patent EA-033302-B1 (EA)
Title: (6r,10r)-6,10,14-trimetylpentadecan-2-one prepared from 6,10,14-trimetylpentadeca-5,9,13-trien-2-one or 6,10,14-trimetylpentadeca-5,9-dien-2-one
Inventor: BONRATH WERNER
IPC: C07C45/62
Filed: 2013-12-18
Abstract: The present invention relates to a process of manufacturing a specific isomer (6R,10R)-6,10,14-trimetylpentadecan-2-one in a multistep synthesis from a mixture of isomers (5E,9E)-, (5E,9Z)-, (5Z,9E)- and (5Z,9Z)-6,10,14-trimetylpentadeca-5,9,13-trien-2-one or a mixture of isomers (5E,9E)-, (5E,9Z)-, (5Z,9E)- and (5Z,9Z)-6,10,14-trimetylpentadeca-5,9-dien-2-one by asymmetric hydrogenation using molecular hydrogen in the presence of a chiral iridium complex of formula (III), wherein groups and symbols in formula (III) have the meanings defined herein. The process is very advantageous in that it forms in an efficient way the desired chiral product from a mixture of stereoisomers of the starting product.
Patent EA-030354-B1 (EA)
Title: Method for reducing dyspnea in a patient with acute heart failure
Inventor: SPINDLER EDWARD C JR
IPC: A01N37/30
Filed: 2013-10-26
Abstract: The invention relates to a method for reducing dyspnea in a patient in need thereof having acute heart failure and a systolic blood pressure of 120 to less than 160 mmHg, the method comprising the intravenous administration to the patient of a pharmaceutical composition comprising clevidipine at a rate between 1 and about 32 mg/h of clevidipine for a duration of 30 minutes to 72 hours at an initial rate of 2 mg/h of clevidipine.
Patent EA-029119-B1 (EA)
Title: Pharmaceutical composition comprising n-[3-chloro-4-(3-fluorobenzyloxy)phenyl]-6-[5({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]quinazolin-4-amine or a pharmaceutically acceptable salt, solvate or solvated salt thereof
Inventor: ROTHER PATRICK
IPC: A61K9/28
Filed: 2014-02-18
Abstract: The present invention relates to a pharmaceutical composition comprising N-[3-chloro-4-(3-fluorobenzyloxy)phenyl]-6-[5({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]quinazolin-4-amine or a pharmaceutically acceptable salt, solvate or solvated salt thereof, and a process for preparing the pharmaceutical composition.
Patent EA-031344-B1 (EA)
Title: Synthetic detergent for washing kids clothes
Inventor: SAGAJDAK IGOR GENNADIEVICH
IPC: C11D9/42
Filed: 2016-11-01
Abstract: The invention relates to formulations of powder synthetic specialty detergents, particularly to a concentrated powder synthetic detergent for washing kids clothes. The synthetic detergent includes sodium soaps based on higher fatty acids of palm and coconut oils - 10-15%, alkylpolyglucosides with chain length C10-14 - 10-20%, oxygen-containing bleach - sodium percarbonate - 15-25%, activator of bleach - tetraacetylethylenediamine - 1-3%, anti-sorbents - sodium carboxymethyl cellulose - 1-3% and soluble sodium cilicate - 10-15%, complexing agent - sodium salt of methylglycinediacetic acid - 5-9%, sodium carbonate - 7-15%. The technical result consists in increasing the hypoallergenicity of the formulation, reducing its environmental hazard, as well as the cost of the washing process by eliminating ballast salts from the specified formulation while maintaining high rates of washing and bleaching abilities.
Patent EA-033928-B1 (EA)
Title: Method for determining crack resistance characteristics of materials in static elastoplastic deformation
Inventor: BOGDANOVICH ALEXANDER VALDEMAROVICH
IPC: G01N3/34
Filed: 2017-10-23
Abstract: The invention relates to the field of mechanical tests of materials, and more particularly to determining their ability to resist crack increase under the conditions of static elastoplastic deformation and can be used for assessing crack resistance characteristics of ductile materials including low-alloy pipe steels based on measurement of the value of sample contraction in the plane of its breaking. The object of the invention is to develop a method allowing to use, during crack resistance tests, a sample - a pipe element with large (more than 400 mm) diameter preserving the pipe geometry of linear section of a pipeline and its ductile properties and also to use for assessing the stress-intensity factor in a sample with a crack the property of the plastic zone surrounding the apex of crack to absorb energy in the process of crack development, thereby to effect the material resistance against crack growth under the conditions of elastoplastic deformation, that allows to apply a conventional parameter - the stress intensity factor, as well as the deformation parameter - sample contraction in the plane of its breaking, to determine the force and deformation characteristics of crack resistance of a material in elastoplastic deformation.
Patent EA-032415-B1 (EA)
Title: Substituted bicyclic compounds
Inventor: XIAO HAI-YUN
IPC: C07C251/44
Filed: 2015-08-20
Abstract: Disclosed are compounds of Formulas (Ic), (IIc), (IIIc), (IVc) and (Vc)or a pharmaceutically acceptable salt thereof. Also disclosed are methods of using such compounds as selective agonists for G protein coupled receptor SPand pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing or slowing the progression of diseases or disorders, such as autoimmune or chronic inflammatory diseases.
Patent EA-034800-B1 (EA)
Title: Peptide binding to mhc-i, inducing ctl and stimulating anti-tumor immune responses
Inventor: SCHOOR OLIVER
IPC: C07K7/06
Filed: 2008-07-25
Abstract: The invention relates to a peptide 9-30 amino acids in length capable of binding to a human major histocompatibility complex (MHC) class-I molecule, inducing cytotoxic CD8 T lymphocytes and stimulating anti-tumor immune responses. The invention also relates to a method of producing said peptide; a host cell comprising a nucleic acid encoding said peptide, or a vector expressing said nucleic acid; an activated CTL and a method for producing the same; the use of said peptide, said host cell and activated CTL for the manufacture of a medicament for treating cancer; the use of said peptide for producing specific antibodies to MHC/peptide complexes.
Patent EA-036926-B1 (EA)
Title: Antibacterial composition to deliver gramicidin c to a site of local inflammation, method of producing an antibacterial composition to deliver gramicidin c to a site of local inflammation, method of delivering gramicidin c to a site of local inflammation
Inventor: Kalustov Vladlen Borisovich
IPC: A61P31/04
Filed: 2018-06-06
Abstract: The claimed technical solution relates to the field of medicine and hygiene, and may be used to suppress the growth of pathogenic microflora at a site of local inflammation in the human body in order to increase the effectiveness of therapy of infectious inflammatory diseases of the mouth and throat, specifically acute tonsillitis (sore throat), pharyngitis, periodontal disease, gingivitis, and stomatitis. The aims of the claimed technical solution are to develop an antibacterial composition that would deliver Gramicidin C to a site of local inflammation and would be sprayable, and that would be capable of most precisely delivering Gramicidin C to the site of local inflammation, covering each section of the site, and that would have minimal side effects on the human body; to develop a simple method for producing it; and to develop a method for arranging the delivery of the antibacterial composition to a site of local inflammation that would enable treatment of the entire surface of the site of local inflammation while minimally affecting adjacent tissues.
Patent EA-038185-B1 (EA)
Title: Wall system for a furnace, furnace comprising such a wall system and method for installing such a wall system
Inventor: ZIVANOVIC BOJAN
IPC: F27B3/08
Filed: 2017-06-12
Abstract: The invention relates to a wall system for a furnace, a furnace comprising such a wall system and a method for installing such a wall system.
Patent ES-2174743-B1 (ES)
Title: Sistema electromecanico de representacion de imagenes.
Inventor: ESTOPINAN CANALS MANUEL
IPC: G02B27/22
Filed: 1998-12-24
Granted: 2003-07-16
Abstract: Comprende como mínimo una línea (7) formada por "n" puntos luminosos (3), que gira alrededor de un eje (1) de accionamiento, a efectos de generar una imagen virtual (6) formada en el espacio, cuyo relieve o profundidad estaría en función del número "n" de líneas (7). El eje (1) es accionado por un motor (4), sincronizado y gobernado todo ello en el tiempo por un ordenador o microprocesador (5). La transmisión de la información del ordenador (5), a los puntos luminosos (3) se realiza por vía radio, infrarrojos, ópticamente, o magnéticamente, a través de un circuito de control (14).
Patent ES-2182710-B1 (ES)
Title: Marcador electronico para eventos y pruebas deportivas.
Inventor: BRETOS JAVIERRE JOSE LUIS
IPC: G09F7/10
Filed: 2001-07-10
Granted: 2004-06-01
Abstract: Marcador electrónico para eventos y pruebas deportivas dotado de una zona de presentación de información (1) conformada por diferentes pisos (2), configurando cada piso varias caras, disponiendo cada cara de un bastidor (3), el cual está dotado de un canal en "U" (4), para el asentamiento de unos marcos modulares (5), los cuales una vez colocados, pueden desplazarse a través del mismo fijándose por atornillamiento tipo palomita o similar (6); cada marco modular (5) está compuesto por diferentes placas (7), fijadas mediante atornillamiento u otro medio, las cuales por su cara externa presentan unos señalizadores de biestable o tipo led (8), mientras que por su cara interna, disponen de conexiones de rápido montaje (9), a un controlador de activación (10), que procesa la señal de un controlador general (11) conectado a su vez a un ordenador central (12), estando compuesto el controlador general (11) por dos placas procesadoras, una de trabajo y otra de seguridad, y presentando un sistema de conexiones o cables de doble canal (13).